This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Zymogenetics, Inc., University of Washington. Active years: 1997-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
10 out of 723 
2 out of 2,172 
Years Active: 1997-2007
Title: Catherine E Lofton-Day: Innovator in Tumor Necrosis Factor Receptor Research
Introduction
Catherine E Lofton-Day is a prominent inventor based in Brier, WA, with an impressive portfolio of 10 patents. Her groundbreaking work focuses on polypeptides and their applications in health and medical science, significantly contributing to advancements in cancer research and reproductive health.
Latest Patents
Among her latest innovations, Catherine has developed novel polypeptides related to tumor necrosis factor receptors (TNFR). These innovative compounds, alongside polynucleotides encoding them, have potential applications for detecting ligands, agonists, and antagonists. Notably, these polypeptides can be employed in methods that influence inflammation, tumor growth and metastasis, infections, immunity, and cellular maturation.
Additionally, she has introduced testis-specific insulin homolog polypeptides and their corresponding polynucleotides. These inventions are particularly valuable in assisted reproductive technologies, aiming to enhance the viability of cryopreserved sperm, improve sperm motility, and increase fertilization rates. This research also explores contraceptive applications and other related uses.
Career Highlights
Catherine Lofton-Day has had a remarkable career that includes significant roles at Zymogenetics, Inc. and the University of Washington. Her dedicated research and innovative spirit have led to crucial advancements in the field of medicine.
Collaborations
Throughout her career, Catherine has collaborated with esteemed professionals such as Si Lok and Darrell C Conklin. These collaborations have facilitated a robust exchange of ideas and expertise, further enriching her contributions to science.
Conclusion
Catherine E Lofton-Day stands out as an influential inventor whose work has far-reaching implications in healthcare. Her patented innovations in tumor necrosis factor receptor research and reproductive health underscore her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile